Muco Rhinathiol Erwachsene (Carbocisteine)

Carbocisteine acts by breaking disulfide bonds in mucoproteins, which reduces the viscosity of mucus. This makes the sputum less sticky and easier for ciliary movement and coughing to clear from the airways, improving ventilation and reducing cough severity.

The specific dose of Muco Rhinathiol Erwachsene is determined by the prescribing healthcare professional based on the patient’s condition, age, and overall health. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for carbocisteine in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing it to pregnant or nursing women. It is generally recommended to use only if clearly needed.

To request Muco Rhinathiol Erwachsene, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Carbocisteine differs from agents like acetylcysteine by primarily cleaving disulfide bonds in mucoproteins rather than acting as a direct antioxidant. It is often preferred for its tolerability profile and effectiveness in chronic bronchitis, while other mucolytics may be chosen for specific indications such as acetaminophen overdose protection.

Muco Rhinathiol Erwachsene should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The medication is taken orally, usually in tablet or syrup form, as directed by a healthcare professional. It should be swallowed with a glass of water and can be taken with or without food, unless the prescriber advises otherwise.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and significant liver or kidney dysfunction. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, jaundice, or sudden breathing difficulty.

Individuals with a known hypersensitivity to carbocisteine or any component of the formulation should avoid using the product. It is also contraindicated in patients with severe renal impairment unless dosage adjustments are made by a qualified clinician.